Case study of CardioDx reveals direction of General Electric's $250m healthcare corporate venturing fund set up late last year.
US-based conglomerate General Electric Company has made its first investment out of its new corpo- rate venturing fund with a $5m backing of California-based CardioDx.
The CardioDx investment was made out of the $250m GE Healthymagination fund and is part of a larger round, which a regulatory filing seen by news provider www.pehub.com suggests could be worth more than $45.5m.
The GE Healthymagination fund was launched in October to identify and partner healthcare technology companies as part of…
